Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cell Tracking | 2 | 2021 | 144 | 0.900 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome, Type 1 | 1 | 2021 | 3 | 0.810 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome | 1 | 2021 | 9 | 0.810 |
Why?
|
Hematopoietic Stem Cells | 10 | 2023 | 3353 | 0.780 |
Why?
|
Clone Cells | 2 | 2021 | 1697 | 0.660 |
Why?
|
Epitopes | 2 | 2023 | 2560 | 0.650 |
Why?
|
Gene Targeting | 4 | 2017 | 885 | 0.530 |
Why?
|
Targeted Gene Repair | 1 | 2014 | 19 | 0.510 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 24 | 0.500 |
Why?
|
Antigens, CD34 | 4 | 2023 | 653 | 0.490 |
Why?
|
Lentivirus | 5 | 2018 | 498 | 0.390 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3400 | 0.360 |
Why?
|
Immunotherapy | 1 | 2023 | 4257 | 0.320 |
Why?
|
Software | 1 | 2021 | 4406 | 0.300 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 2 | 2017 | 46 | 0.280 |
Why?
|
Zinc Fingers | 3 | 2012 | 587 | 0.240 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10007 | 0.240 |
Why?
|
Fanconi Anemia | 2 | 2017 | 321 | 0.230 |
Why?
|
Epitope Mapping | 1 | 2023 | 312 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2017 | 2414 | 0.210 |
Why?
|
Hematopoiesis | 3 | 2023 | 2056 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2023 | 3574 | 0.200 |
Why?
|
Genome, Human | 1 | 2014 | 4430 | 0.190 |
Why?
|
Genetic Vectors | 5 | 2021 | 3447 | 0.190 |
Why?
|
Tumor Escape | 1 | 2023 | 346 | 0.190 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2021 | 131 | 0.190 |
Why?
|
Interleukin Receptor Common gamma Subunit | 3 | 2017 | 87 | 0.180 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 2012 | 172 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2023 | 5215 | 0.180 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1553 | 0.140 |
Why?
|
DNA, Complementary | 2 | 2022 | 2073 | 0.140 |
Why?
|
Cyclosporine | 1 | 2018 | 791 | 0.140 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2013 | 87 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2018 | 923 | 0.130 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2768 | 0.130 |
Why?
|
Gene Transfer Techniques | 4 | 2017 | 1242 | 0.130 |
Why?
|
Adoptive Transfer | 1 | 2017 | 853 | 0.130 |
Why?
|
B-Lymphocyte Subsets | 1 | 2015 | 252 | 0.120 |
Why?
|
Lymphocyte Activation | 2 | 2022 | 5544 | 0.110 |
Why?
|
Mice | 12 | 2022 | 80300 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1576 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2937 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2015 | 312 | 0.100 |
Why?
|
Animals | 13 | 2023 | 168714 | 0.100 |
Why?
|
Recurrence | 1 | 2023 | 8212 | 0.100 |
Why?
|
Fetal Blood | 2 | 2017 | 1311 | 0.100 |
Why?
|
Endonucleases | 1 | 2014 | 380 | 0.100 |
Why?
|
Integrases | 2 | 2011 | 539 | 0.100 |
Why?
|
DNA Damage | 2 | 2019 | 2466 | 0.100 |
Why?
|
HIV Integrase | 1 | 2011 | 118 | 0.090 |
Why?
|
Immunologic Memory | 1 | 2017 | 1347 | 0.090 |
Why?
|
Endodeoxyribonucleases | 1 | 2011 | 165 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2019 | 1873 | 0.090 |
Why?
|
Leukemia | 2 | 2021 | 1494 | 0.090 |
Why?
|
Antigens, Neoplasm | 2 | 2015 | 1944 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 2 | 2015 | 1105 | 0.080 |
Why?
|
Mutagenesis, Insertional | 1 | 2011 | 657 | 0.080 |
Why?
|
Mice, SCID | 3 | 2019 | 2724 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1739 | 0.080 |
Why?
|
Multiple Myeloma | 2 | 2017 | 5068 | 0.080 |
Why?
|
Dependovirus | 3 | 2020 | 719 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2011 | 603 | 0.070 |
Why?
|
Genetic Engineering | 2 | 2015 | 946 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2934 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9245 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1845 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2017 | 5037 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3711 | 0.060 |
Why?
|
Hepatocytes | 1 | 2011 | 1196 | 0.060 |
Why?
|
Humans | 19 | 2023 | 725187 | 0.050 |
Why?
|
Immune Tolerance | 1 | 2011 | 2253 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2760 | 0.050 |
Why?
|
Base Sequence | 3 | 2020 | 12991 | 0.050 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2021 | 42 | 0.050 |
Why?
|
G2 Phase | 1 | 2020 | 142 | 0.050 |
Why?
|
Cytokines | 1 | 2015 | 7180 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4225 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1328 | 0.050 |
Why?
|
S Phase | 1 | 2020 | 432 | 0.040 |
Why?
|
DNA Repair | 1 | 2007 | 2047 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16630 | 0.040 |
Why?
|
Virus Integration | 2 | 2011 | 298 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 624 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5358 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2017 | 19485 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 16263 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2013 | 39 | 0.030 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2013 | 29 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14769 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 2860 | 0.030 |
Why?
|
Interleukin-7 | 1 | 2013 | 140 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2013 | 167 | 0.030 |
Why?
|
Viral Proteins | 1 | 2020 | 1952 | 0.030 |
Why?
|
Lymphoma | 1 | 2021 | 1858 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2020 | 2383 | 0.030 |
Why?
|
Antigens, CD | 1 | 2022 | 4052 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2012 | 178 | 0.030 |
Why?
|
Cell Lineage | 1 | 2020 | 2519 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4234 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 749 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2079 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2013 | 1365 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29672 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2093 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1805 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2007 | 210 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 1803 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3902 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7814 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9789 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3800 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2761 | 0.020 |
Why?
|
Transgenes | 1 | 2007 | 1016 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3529 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 4198 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1638 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6133 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1633 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19624 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6431 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2562 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4875 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9469 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18301 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9700 | 0.010 |
Why?
|
Male | 1 | 2014 | 347096 | 0.010 |
Why?
|
Female | 3 | 2018 | 375449 | 0.010 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_